Introduction {#sec0005}
============

*Streptococcus canis* (Sc) is a zoonotic pathogen that is transferred primarily from companion animals such as dogs and cats to humans through both animal bites and other mechanisms, and usually infects immunocompromised rather than immunocompetent hosts. This species has also been isolated from a variety of other animals, including cows, rats, mink, mice, rabbits, and foxes [@bib0005]. Sc strains are β-hemolytic, and they appear as large white colonies surrounded by zones of complete hemolysis when cultured on sheep blood agar plates. Furthermore, Lancefield grouping, based on the composition of carbohydrate antigens in the cell wall, was used to classify Sc as a group G streptococcus. The filamentous M protein is a major somatic virulence factor in group A streptococci, and the M-like protein produced by Sc strains is thought to play a similar role in Sc [@bib0010]. We present the first reported human case of uncomplicated bacteremia following a dog bite, caused by Sc harboring the *scm* gene, which encodes M-like protein. Furthermore, we review published reports of the clinical and microbiological characteristics of Sc infection in humans.

Case report {#sec0010}
===========

A 71-year-old man was admitted to our hospital with swelling and redness in his right leg, complicated by fever and rigor. His underlying medical conditions included atrial fibrillation, hypertension, superior mesenteric vein thrombosis, liver cirrhosis (LC) following infection with Hepatitis C Virus. He had received a splenectomy for splenomegaly due to LC. One year prior to admission, he had received the non-conjugated, pneumococcal polysaccharide vaccine because of the splenectomy. The patient was the owner of a dog that had become sick and had bitten his right leg several days previously. On admission to the emergency room, the patient exhibited a temperature of 40.2 °C, blood pressure of 150/110, a respiratory rate of 25 breaths/min, and an oxygen saturation of 94% (equivalent to the ambient concentration), and he was tachycardic with a heart rate of 106 bpm. The clinical examination was unremarkable with the exception of a systolic murmur (Levine II/VI) at the apex and the remarkable swelling and redness of his right leg. The leukocyte cell count and C-reactive protein concentration were 8500/μL and 0.30 mg/dL, respectively. Transthoracic echocardiography showed no evidence of vegetation that might indicate endocarditis, and a computed tomography scan of the chest, abdomen, and pelvis revealed no evidence of infective foci.

Cellulitis was diagnosed and the intravenous administration of the antibiotic cefmetazole was initiated (4 g per day, administered as two 2-g doses); however, concerns about severe infection were raised, because he had undergone a splenectomy. After admission, duplicate blood cultures revealed the presence of gram-positive cocci, and the cefmetazole treatment was replaced by the combined intravenous administration of ampicillin (12 g per day, administered as six 2-g doses) and clindamycin (1800 mg per day, administered as three 600-mg doses). The patient-origin samples were cultured on a sheep blood agar plate for 24 h at 35 °C in 5% CO~2~, resulting in the growth of large, smooth, white, non-mucoid β-hemolytic colonies with group G carbohydrate antigens ([Fig. 1](#fig0005){ref-type="fig"}).

The infecting species was matched to Sc with 99.9% probability, using a Rapid ID 32 Strep API system (SYSMEX bioMérieux Co. Ltd., Tokyo, Japan) to assess its biochemical parameters. Unfortunately, the dog died from the disease and the Sc strain could not be isolated from the dog. The isolate from the patient was stored at −80 °C for further characterization.

In summary, the patient was diagnosed with uncomplicated bacteremia caused by Sc, and was treated with a 2-week course of combined ampicillin and clindamycin therapy at set doses. The treatment was successful, and the patient remained well with no recurrence of bacteremia during the 4-month follow-up period.

Microbiological analyses {#sec0015}
========================

The phenotypic and genotypic characteristics of the isolate were determined, and are summarized in [Table 1](#tbl0005){ref-type="table"}. The identification of the isolated species as Sc was confirmed by sequencing the 16S rRNA (read length 1426 bp); the isolate displayed 99.02% identity to Sc strain ATCC 43496(T). Furthermore, it was possible to amplify the *cfg* gene, encoding a CAMP factor co-hemolysin found in Sc [@bib0015], from the extracted DNA. Additionally, it was possible to detect the presence of a *scm* gene, encoding the major virulence factor M-like protein [@bib0020]; the amplified sequence (read length 912 bp) was closely related to *scm* from other two Sc strains: 321 324A (accession no. [KF662395.1](ncbi-n:KF662395.1){#intr0025}) and 341 4291B (accession no. [KF662396.1](ncbi-n:KF662396.1){#intr0030}) ([Fig. 2](#fig0010){ref-type="fig"}). Multilocus sequence typing (MLST) was performed by cross-referencing the sequences of 7 housekeeping genes (*gki*, *gtr*, *murI*, *mutS*, *recP*, *xpt*, and *yqiZ*) from our isolate with those registered into the Sc MLST database (<http://pubmlst.org/scanis/>). The isolate was found to be a sequence type (ST) 9 strain, possessing the allelic profiles 3, 5, 3, 3, 1, 2, and 3 for each of the seven genes, respectively.

Antimicrobial susceptibility assays revealed that the Sc isolate was susceptible to penicillin, cephalosporin, tetracyclines (TCs), glycopeptides, lincomycins, sulfamethoxazole/trimetoprim, chloramphenicol, and fluoroquinolones. Susceptibility to macrolides was mixed, as the isolate was susceptible to erythromycin but not to azithromycin: its susceptibility was intermediate. It should be noted, however, that the breakpoints of antibiotic concentrations used to determine susceptibility were those for viridans group streptococci, since no breakpoints for Sc are described in the Clinical and Laboratory Standards Institute guidelines. While this susceptibility testing suggested that the isolate might be resistant to azithromycin, our PCR-based results indicated that this isolate did not possess the macrolide/lincosamide (ML) resistance genes, *erm*(A), *erm*(B) or *mef*(A) [@bib0025].

Discussion {#sec0020}
==========

To the best of our knowledge, this is the first reported human case of uncomplicated bacteremia caused by an ST9 Sc harboring the *scm* gene. The M-like protein expressed by the *scm* gene is a novel virulence factor with possibility of anti-phagocytic activity. Additionally, this protein acts cooperatively with enolase to bind to the C-terminal mini-plasminogen region of plasminogen, recruiting the latter to the bacterial surface and enhancing the transmigration and survival of the bacterium [@bib0010], [@bib0020]. However, not all Sc strains isolated from animals possess the *scm* gene; one study detected the *scm* gene in only thirteen of nineteen strains examined (68.4%) [@bib0020]. Consistent with this result, a separate study found that 90.0% of canine and 83.3% of feline Sc strains harbored the M-like protein [@bib0030]. In this study, it was not possible to isolate and identify the Sc strain directly from the pet dog of the patient, since the dog died from the illness while the patient was hospitalized, and we need to confirm the presence of the *scm* gene among Sc strains prospectively recovered from companion animals in Japan.

The MLST method for typing Sc strains has been established [@bib0035], and ST9 was found to be the most prevalent type among the 85 Sc isolates (23/85; 27.1%), including among strains originating in humans (*n* = 5). According to information in the MLST database, ST9 strains are isolated from cats, dogs, and cows from Germany, Portugal, and the US. Reported sources of ST9 Sc isolates were skin and soft tissue exudate, vaginal exudate, ear exudate, urine, and others. Several human infections with the ST9, the prevalent ST, originating from Portugal, are registered into the database; the tissue sources of infection were skin and soft tissue exudate, respiratory tract secretions, and blood specimens. The human cases caused by other STs 2, 3, 4, 12, and 14 also originated in Portugal and the US. In this case study, we describe a human infection with a pathogenic ST9 Sc strain harboring the *scm* gene, and in future it will be interesting to analyze the relationship between the presence of the *scm* gene and the ST of the Sc strains isolated from companion animals and humans in Japan.

The isolate in this case did not possess the ML-resistance genes, *erm*(A), *erm*(B), or *mef*(A), although azithromycin was not effective against this bacterium. Previously, resistance rates of 27% against TC and 10.8% against ML were reported among 37 Sc strains isolated from dogs between 2000 and 2005 [@bib0040]. Additionally, the presence of the resistance genes *tet*(M) or *tet*(O) alone, or combinations of resistance genes \[*tet*(M)/*tet*(L), *tet*(L)/*tet*(S), and *tet*(O)/*erm*(B)\] have been detected in TC-resistant SC isolates (*n* = 23; resistance rate, 27%) [@bib0035]. Therefore, ML- and/or TC-resistance should be considered when antimicrobials are found to be ineffective in veterinary clinical practice.

Sc infection is rare, but host characteristics linked to susceptibility to infection, including the immunity, have been described previously. In humans, underlying medical conditions, particularly diabetes mellitus, can increase the susceptibility, as can a compromised immune system [@bib0045], [@bib0050]. On the other hand, the presence of virulence factors could enhance the potential infectivity with Sc; we have described the presence of the M-like protein virulent factor in this case, but it is possible that other virulent factors might enhance Sc pathogenesis in immunocompetent individuals, and their investigation using comprehensive approaches including genome sequencing [@bib0055] and proteomics will be important in the future.

The entry site of Sc into human host should also be considered. Most cases of Sc infection, except for dog bites, originate in pre-existing wounds and skin ulcers [@bib0060], [@bib0065]. Notably, however, Ohtaki and colleagues recently reported the first documented human case of sepsis caused by Sc without a dog bite in Japan [@bib0070]. While the entry mechanism remains unclear, we speculate that the pathogenic Sc, which may be resident at/around the oropharynx, skin, genitourinary tract, and anal tract, seem to invade the host through invisible wounds on human skin [@bib0075], [@bib0080].

Conclusion {#sec0025}
==========

Companion animals kept in households are hugely important to individuals of all ages in Japan, so much so that some human hospitals have introduced Animal-Assisted Therapy to improve the mental health of human patients. Therefore, when presented with feverish patients who maintain close contact with these animals, clinicians should consider infection with Sc as well as with *Pasteurella* sp., *Prevotella* sp., and *Capnocytophaga* sp. Furthermore, since an animal's life is completely controlled by its human owner, the "One Health" concept, which recognizes that human health and animal health are connected [@bib0085], should be employed to study the crosstalk concerning bacteria, including Sc, that infect both humans and animals, to maintain their future health.
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![Morphological features of large, smooth, white, non-mucoid β-hemolytic colonies of *Streptococcus canis*. The microorganism was cultured on a sheep blood agar plate for 24 h at 35 °C in 5% CO~2~.](gr1){#fig0005}

![Multi-alignment of our isolate (TA4) and other two strains of *Streptococcus canis* (321 324A and 341 4291B), generated using CLUSTALW version 2.1 (<http://clustalw.ddbj.nig.ac.jp/>).](gr2){#fig0010}
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Phenotypic and genotypic characteristics and antimicrobial susceptibility results of *Streptococcus canis* isolate from a human case.

Table 1

  Phenotypic and genotypic parameters                                                                                            Strain TA4
  ------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------------------------------------------------------------
  Clinical specimen                                                                                                              Blood
  Gross appearance of colonies on a sheep blood agar plate                                                                       Non-mucoid, beta-hemolytic large-size white smooth colonies
  Carbohydrate group (Lancefield antigen)                                                                                        G
  Numerical profile using the Rapid ID 32 Strep API system (% identification)                                                    57116441 (99.9)
  Similarity (%) to *S. canis* type strain[a](#tblfn0005){ref-type="table-fn"} using 16S rRNA sequencing (sequencing size, bp)   99.02 (1426)
  Amplification of *cfg* gene encoding a co-hemolysin, CAMP-factor                                                               Positive
  Amplification and sequencing of *scm* gene encoding M-like protein (sequencing size, bp)                                       Similarity to those of *S*. *canis* strains 321 324A and 341 4291B[b](#tblfn0010){ref-type="table-fn"} (912)
  Sequence type (allelic profile: *gki-gtr-murI-mutS-recP-xpt-yqiZ*)                                                             9 (3-5-3-3−1-2-3)
  Non-susceptible antimicrobial agent[c](#tblfn0015){ref-type="table-fn"}                                                        Azithromycin alone
  Macrolide/lincosamide resistance determinant                                                                                   None
                                                                                                                                 
  Antimicrobial agents                                                                                                           Minimum inhibitory concentration (μg/mL)
  Penicillin G                                                                                                                   ≤0.03
  Ampicillin                                                                                                                     ≤0.06
  Amoxicillin/clavulanic acid                                                                                                    ≤0.25
  Cefotiam                                                                                                                       ≤0.5
  Cefotaxime                                                                                                                     ≤0.12
  Ceftriaxone                                                                                                                    ≤0.12
  Cefepime                                                                                                                       ≤0.5
  Cefozopran                                                                                                                     ≤0.12
  Cefditoren pivoxil                                                                                                             ≤0.06
  Meropenem                                                                                                                      ≤0.12
  Erythromycin                                                                                                                   ≤0.12
  Azithromycin                                                                                                                   1
  Clindamycin                                                                                                                    ≤0.12
  Minocycline                                                                                                                    ≤0.5
  Chloramphenicol                                                                                                                ≤4
  Vancomycin                                                                                                                     0.5
  Levofloxacin                                                                                                                   0.5
  Sulfamethoxazole-trimethoprim                                                                                                  ≤0.5

*S. canis* ATCC 43496(T).

*Scm* accession numbers of strains 321 [324A](pdb:324A){#intr0010} and 341 4291B were [KF662395.1](ncbi-n:KF662395.1){#intr0015} and [KF662396.1](ncbi-n:KF662396.1){#intr0020}, respectively.

Resistance to antimicrobials was determined by the broth microdilution method according to the Clinical and Laboratory Standards Institute document M100-S22.
